Evidence map›Paper›PMID 34754318›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2021

Mechanism of Action of Dengzhan Shengmai in Regulating Stroke from an Inflammatory Perspective: A Preliminary Analysis of Network Pharmacology.

Yiqi Yan, Chao Sun, Xiaoting Rong, Rui Han, Shan Zhu, Rui Su, Ya Jin, Lin Li, Jun Liu

Open access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yiqi YanLaboratory of Pharmacology of Traditional Chinese Medicine Formulae Co-Constructed By the Province-Ministry, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Chao SunGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Xiaoting RongTianjin Central Hospital of Gynecology Obstetrics, Tianjin 300121, China.
Rui HanLaboratory of Pharmacology of Traditional Chinese Medicine Formulae Co-Constructed By the Province-Ministry, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Shan ZhuLaboratory of Pharmacology of Traditional Chinese Medicine Formulae Co-Constructed By the Province-Ministry, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Rui SuLaboratory of Pharmacology of Traditional Chinese Medicine Formulae Co-Constructed By the Province-Ministry, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Ya JinLaboratory of Pharmacology of Traditional Chinese Medicine Formulae Co-Constructed By the Province-Ministry, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
Lin LiLaboratory of Pharmacology of Traditional Chinese Medicine Formulae Co-Constructed By the Province-Ministry, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.ORCID https://orcid.org/0000-0002-1103-2185
Jun LiuGraduate School, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.ORCID https://orcid.org/0000-0001-7253-6283
Tianjin University of Traditional Chinese Medicine · CNTianjin Central Hospital of Gynecology Obstetrics · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a complicated disease with an increasing incidence and a very high mortality rate. A classical Chinese herbal medicine, Dengzhan Shengmai (DZSM), has shown to have therapeutic effects on stroke; however, its chemical basis and molecular mechanism are still unclear. In this study, a systems biology approach was applicable to elucidate the underlying mechanism of action of DZSM on stroke. All the compounds were obtained from databases, and pendant-related targets were obtained from various data platforms, including the TCM Systematic Pharmacology (TCMSP) database, TCM Integrated Database (TCMIP), High Throughput Experimental Reference Database (HERB), Comparative Toxicogenomics Database (CTD), SwissTargetPredicition, and SymMap, The Human Gene Database (GENECARD) and Comparative Toxicogenomics Database (CTD) were used for stroke disease target data, followed by network pharmacology analysis to predict the potential effect of DZSM on stroke. Animal experiments were intended to validate the underlying mechanisms. A total of 846 chemical components were compiled for the targets of DZSM drug, and quercetin, kaempferol, and Wuweizisu C are the highest chemical components compiled from DZSM. Overlapping with 375 disease-specific targets and 149 core targets, the core targets include TNF, IL-6, ALB, and AKT1, which are shown to regulate the disease process from an anti-inflammatory perspective. 198 enrichment messages were obtained by KEGG enrichment analysis, and we believe that the role of the AGE-RAGE signaling pathway in diabetic complications, TNF signaling pathway, and IL-17 signaling pathway is more important. Based on rat experiments, we also demonstrated that DZSM could effectively modulate the inflammation level of brain infarct tissues and effectively alleviate behavioral characteristics. Grouped together, our study suggests that the combination of network pharmacology prediction and experimental validation can provide a useful tool to describe the molecular mechanisms of DZSM in Chinese medicine (TCM).

Identifiers

PMID34754318
PMCPMC8572589
OpenAlexW3209191933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.